Mangoceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -325.4% | -325.4% | -199.2% |
| FY2023 | -1,189.1% | -1,189.1% | -876.7% |
| FY2024 | -62.4% | -62.4% | -56.6% |
| FY2025 | -135.8% | -135.8% | -128.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -325.4% | -325.4% | -199.2% |
| FY2023 | -1,189.1% | -1,189.1% | -876.7% |
| FY2024 | -62.4% | -62.4% | -56.6% |
| FY2025 | -135.8% | -135.8% | -128.3% |